{"organizations": [], "uuid": "59ca74a96201fa433c23bb2d88df774ec35ceb97", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.bio-medicine.org", "main_image": "", "site_section": "http://www.bio-medicine.org/inc/biomed/medicine-technology.asp", "section_title": "Latest Medical Technology from Bio-Medicine.Org", "url": "http://www.bio-medicine.org/medicine-technology-1/Boehringer-Ingelheims-investigational-biologic-cleared-skin-better--faster-and-for-longer-than-ustekinumab-in-phase-II-psoriasis-study-48731-1/", "country": "US", "title": "Boehringer Ingelheim's investigational biologic cleared skin better, faster and for longer than ustekinumab in phase II psoriasis study", "performance_score": 0, "site": "bio-medicine.org", "participants_count": 0, "title_full": "Boehringer Ingelheim's investigational biologic cleared skin better, faster and for longer than ustekinumab in phase II psoriasis study", "spam_score": 0.0, "site_type": "news", "published": "2015-10-08T14:37:00.000+03:00", "replies_count": 0, "uuid": "59ca74a96201fa433c23bb2d88df774ec35ceb97"}, "author": "", "url": "http://www.bio-medicine.org/medicine-technology-1/Boehringer-Ingelheims-investigational-biologic-cleared-skin-better--faster-and-for-longer-than-ustekinumab-in-phase-II-psoriasis-study-48731-1/", "ord_in_thread": 0, "title": "Boehringer Ingelheim's investigational biologic cleared skin better, faster and for longer than ustekinumab in phase II psoriasis study", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": ["Boehringer Ingelheim"], "text": " ", "external_links": [], "published": "2015-10-08T14:37:00.000+03:00", "crawled": "2015-10-08T15:57:17.894+03:00", "highlightTitle": ""}